0001062993-24-016707.txt : 20240917 0001062993-24-016707.hdr.sgml : 20240917 20240917183647 ACCESSION NUMBER: 0001062993-24-016707 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240914 FILED AS OF DATE: 20240917 DATE AS OF CHANGE: 20240917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yoder Robert T CENTRAL INDEX KEY: 0001761214 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36193 FILM NUMBER: 241305701 MAIL ADDRESS: STREET 1: 955 CHESTERBROOK BOULEVARD, SUITE 110 STREET 2: SUITE 200 CITY: CHESTERBROOK STATE: PA ZIP: 19087 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREVENA INC CENTRAL INDEX KEY: 0001429560 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 955 CHESTERBROOK BOULEVARD STREET 2: SUITE 110 CITY: CHESTERBROOK STATE: PA ZIP: 19087 BUSINESS PHONE: 6103548840 MAIL ADDRESS: STREET 1: 955 CHESTERBROOK BOULEVARD STREET 2: SUITE 110 CITY: CHESTERBROOK STATE: PA ZIP: 19087 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0508 4 2024-09-14 0001429560 TREVENA INC TRVN 0001761214 Yoder Robert T C/O TREVENA, INC. 955 CHESTERBROOK BOULEVARD, SUITE 110 CHESTERBROOK PA 19087 0 1 0 0 SVP, Chief Business Officer 0 Common Stock 2024-09-14 4 F 0 487 5.95 D 5868 D The transaction reported represents the withholding of shares by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the non-reportable vesting and settlement of restricted stock units ("RSUs"). These are shares withheld in connection with the non-reportable accelerated vesting and settlement of (i) RSUs granted on December 17, 2020, December 2, 2021, January 6, 2023, and December 14, 2023, and (ii) performance stock units ("PSUs") granted on January 6, 2023. The RSUs and PSUs were subject to accelerated vesting, pursuant to the terms of the Reporting Person's employment agreement with the Issuer, as of the date of the termination of such agreement and transition to a new agreement. The Issuer effected a 1-for-25 reverse stock split of its common stock on Auust 13, 2024. The number of securities reported on this Form 4 has been adjusted to reflect the reverse stock split. /s/ Barry Shin, as Attorney-in-Fact 2024-09-17